Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.

Koutsogiannouli EA, Wagner N, Hader C, Pinkerneil M, Hoffmann MJ, Schulz WA.

Int J Mol Sci. 2017 Jul 5;18(7). pii: E1449. doi: 10.3390/ijms18071449.

2.

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J, Illerhaus G.

Leukemia. 2017 Apr;31(4):846-852. doi: 10.1038/leu.2016.334. Epub 2016 Nov 15.

3.

Selective Venous Blood Sampling for Hyperparathyroidism with unclear Localization of the Parathyroid Gland.

Hader C, Uder M, Loose RW, Linnemann U, Bertsch T, Adamus R.

Rofo. 2016 Dec;188(12):1144-1150. Epub 2016 Sep 19.

4.

Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung.

Reichegger H, Jochum W, Förbs D, Hader C, Früh M.

Oncol Res Treat. 2016;39(7-8):461-3. doi: 10.1159/000446759. Epub 2016 Jun 15.

5.

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.

Illerhaus G, Kasenda B, Ihorst G, Egerer G, Lamprecht M, Keller U, Wolf HH, Hirt C, Stilgenbauer S, Binder M, Hau P, Edinger M, Frickhofen N, Bentz M, Möhle R, Röth A, Pfreundschuh M, von Baumgarten L, Deckert M, Hader C, Fricker H, Valk E, Schorb E, Fritsch K, Finke J.

Lancet Haematol. 2016 Aug;3(8):e388-97. doi: 10.1016/S2352-3026(16)30050-3. Epub 2016 Jul 13.

PMID:
27476790
6.

[Meningioma: management of the most common brain tumour].

Hundsberger T, Surbeck W, Hader C, Putora PM, Conen K, Roelcke U.

Praxis (Bern 1994). 2016 Apr 13;105(8):445-51. doi: 10.1024/1661-8157/a002320. Review. German.

PMID:
27078728
7.

Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer.

Rothermundt C, Hader C, Gillessen S.

Ann Oncol. 2016 Mar;27(3):544-5. doi: 10.1093/annonc/mdv581. Epub 2015 Nov 29. No abstract available.

PMID:
26621192
8.

MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.

Kwok B, Hall JM, Witte JS, Xu Y, Reddy P, Lin K, Flamholz R, Dabbas B, Yung A, Al-Hafidh J, Balmert E, Vaupel C, El Hader C, McGinniss MJ, Nahas SA, Kines J, Bejar R.

Blood. 2015 Nov 19;126(21):2355-61. doi: 10.1182/blood-2015-08-667063. Epub 2015 Oct 1.

9.

Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.

Bausch B, Wellner U, Peyre M, Boedeker CC, Hes FJ, Anglani M, de Campos JM, Kanno H, Maher ER, Krauss T, Sansó G, Barontini M, Letizia C, Hader C, Schiavi F, Zanoletti E, Suárez C, Offergeld C, Malinoc A, Zschiedrich S, Glasker S, Bobin S, Sterkers O, Ba Huy PT, Giraud S, Links T, Eng C, Opocher G, Richard S, Neumann HP; International Endolymphatic Sac Tumor (ELST) Consortium.

Head Neck. 2016 Apr;38 Suppl 1:E673-9. doi: 10.1002/hed.24067. Epub 2015 Jul 14.

PMID:
25867206
10.

Management of von hippel-lindau disease: an interdisciplinary review.

Schmid S, Gillessen S, Binet I, Brändle M, Engeler D, Greiner J, Hader C, Heinimann K, Kloos P, Krek W, Krull I, Stoeckli SJ, Sulz MC, van Leyen K, Weber J, Rothermundt C, Hundsberger T.

Oncol Res Treat. 2014;37(12):761-71. doi: 10.1159/000369362. Epub 2014 Nov 17. Review. Erratum in: Oncol Res Treat. 2015;38(1-2):50.

11.

Dural arteriovenous fistulas of the hypoglossal canal: systematic review on imaging anatomy, clinical findings, and endovascular management.

Spittau B, Millán DS, El-Sherifi S, Hader C, Singh TP, Motschall E, Vach W, Urbach H, Meckel S.

J Neurosurg. 2015 Apr;122(4):883-903. doi: 10.3171/2014.10.JNS14377. Epub 2014 Nov 21. Review.

PMID:
25415064
12.

Multiple mechanisms mediate resistance to sorafenib in urothelial cancer.

Knievel J, Schulz WA, Greife A, Hader C, Lübke T, Schmitz I, Albers P, Niegisch G.

Int J Mol Sci. 2014 Nov 7;15(11):20500-17. doi: 10.3390/ijms151120500.

13.

Multicenter clinical experience in over 125 patients with the Penumbra Separator 3D for mechanical thrombectomy in acute ischemic stroke.

Behme D, Kowoll A, Mpotsaris A, Hader C, Hechelhammer L, Weber J, Weber W.

J Neurointerv Surg. 2016 Jan;8(1):8-12. doi: 10.1136/neurintsurg-2014-011446. Epub 2014 Nov 3.

PMID:
25366355
14.

Met activation is required for early cytoprotection after ischemic kidney injury.

Mason S, Hader C, Marlier A, Moeckel G, Cantley LG.

J Am Soc Nephrol. 2014 Feb;25(2):329-37. doi: 10.1681/ASN.2013050473. Epub 2013 Oct 17.

15.

Impact of Obstructive Sleep Apnoea on Type 2 Diabetes and Vice Versa.

Rasche K, Keller T, Hader C, Leidag M, Prinz C.

Eur Endocrinol. 2013 Aug;9(2):107-109. doi: 10.17925/EE.2013.09.02.107. Epub 2013 Aug 23. Review.

16.

Vertebral artery dissection associated with sildenafil abuse.

Dersch R, Anastasopoulos C, Hader C, Stich O.

J Clin Neurosci. 2013 May;20(5):742. doi: 10.1016/j.jocn.2012.04.023. Epub 2013 Feb 27.

PMID:
23454143
17.

18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma.

Kasenda B, Haug V, Schorb E, Fritsch K, Finke J, Mix M, Hader C, Weber WA, Illerhaus G, Meyer PT.

J Nucl Med. 2013 Feb;54(2):184-91. doi: 10.2967/jnumed.112.108654. Epub 2012 Dec 18.

18.

[Coil migration after neuroradiologic intervention due to hemorrhage in oropharyngeal carcinoma].

Lüblinghoff N, Weerda N, Hader C, Laszig R.

Laryngorhinootologie. 2013 Mar;92(3):184-5. doi: 10.1055/s-0032-1327580. Epub 2012 Oct 9. German. No abstract available.

PMID:
23047177
19.

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.

Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.

Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1.

PMID:
22944197
20.

Who needs a Wada test? Present clinical indications for amobarbital procedures.

Wagner K, Hader C, Metternich B, Buschmann F, Schwarzwald R, Schulze-Bonhage A.

J Neurol Neurosurg Psychiatry. 2012 May;83(5):503-9. doi: 10.1136/jnnp-2011-300417. Epub 2012 Mar 6.

PMID:
22396439

Supplemental Content

Loading ...
Support Center